Drug Trial Radar · NCT06806852
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone
Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
91
Actual
Start
May 14, 2025
Primary completion
Aug 31, 2027
Study completion Aug 31, 2027
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Feb 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults with head and neck cancer. The purpose of this study is to find out whether combining different study medicines makes tumors shrink in people with head and neck cancer. The tested medicines in this study are antibodies that act in different ways against cancer. BI 770371 and pembrolizumab may help the immune system fight cancer. Cetuximab blocks growth signals and may prevent the tumor from growing. Participants are put into 3 groups randomly. Each group receives a different combination of study medicines. All study medicines are given as an infusion into a vein at the study site. Participants can stay in the study as long as they benefit from treatment. Doctors regularly check the size of the tumor and check whether it has spread to other parts of the body. The doctors also regularly check participants' health and take note of any unwanted effects.
Conditions
- Head and Neck Squamous Cell Carcinoma
Interventions
BI 770371Drug
BI 770371
PembrolizumabDrug
Pembrolizumab
CetuximabDrug
Cetuximab
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective response (OR) with confirmationTime frame: Up to 27 months
Locations
51 sites in 22 countries. Site status is shown where the registry gives one.
Norton Cancer Institute, Downtown
Louisville, Kentucky
M Health Fairview Clinics and Surgery Center - Minneapolis
Minneapolis, Minnesota
The Ohio State University Wexner Medical Center
Columbus, Ohio
Gosford Hospital
Gosford, New South Wales, Australia
Andrew Love Cancer Centre
Geelong, Victoria, Australia
Hospital de Amor
Barretos, Brazil
Liga Norte Riograndense contra o cancer
Natal, Brazil
Fundaçao Faculdade Regional de Medicina de Sao Jose do Rio Preto
São José do Rio Preto, Brazil
MBAL Sveta Sofia
Sofia, Bulgaria
CTR Oscar Lambret
Lille, France
CTR Leon Berard
Lyon, France
HOP Timone
Marseille, France
Institut Gustave Roussy
Villejuif, France
ARENSIA Exploratory Medicine LLC
Tbilisi, Georgia
Städtisches Klinikum Braunschweig gGmbH
Braunschweig, Germany
Universitätsklinikum Jena
Jena, Germany
Universität Leipzig
Leipzig, Germany
Universitätsklinikum Ulm
Ulm, Germany
Semmelweis University
Budapest, Hungary
Clinexpert Gyongyos
Gyöngyös, Hungary
Istituto Scientifico Romagnolo
Meldola (FC), Italy
Azienda Ospedaliera Universitaria Integrata Verona
Verona, Italy
Hokkaido University Hospital
Hokkaido, Sapporo, Japan
Kobe University Hospital
Hyogo, Kobe, Japan
Kansai Medical University Hospital
Osaka, Hirakata, Japan
Shizuoka Cancer Center
Shizuoka, Sunto-gun, Japan
Japanese Foundation for Cancer Research
Tokyo, Koto-ku, Japan
Centro Oncologico Personalizado
México, Mexico
Instituto Nacional de Cancerologia
México, Mexico
Unidad Clinica Farmacologica Bioemagno
Mexico City, Mexico
Centro Oncológico Internacional
Tlajomulco de Zuñiga, Mexico
ARENSIA Exploratory Medicine
Chisinau, Moldova
Center of Oncology of the Lublin Region St. Jana z Dukli
Lublin, Poland
"Prof. Dr. Alexandru Trestioreanu" Oncology Institut
Bucharest, Romania
National University Hospital-Singapore-22806
Singapore, Singapore
Severance Hospital
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
The Catholic University of Korea, St.Vincent's Hospital
Suwon, South Korea
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Cantonspital Aarau
Aarau, Switzerland
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.